Telephone

ALLBIRDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allbirds, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, May 31, 2023
P.C, IPO, Telephone, Person, Complaint, Register, Prospectus, EBITDA, District court, Court, Defendant, Growth, News, Registration statement, Security (finance), Cryptocurrency, Allbirds

Investors have until June 12, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 12, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • In November 2021, Allbirds conducted its IPO, selling approximately 16,850,799 shares of Class A common stock at $15.00 per share.
  • Also on March 9, 2023, after the market closed, Allbirds announced that its Chief Financial Officer was stepping down.
  • The same day, March 9, 2023, the Company held a conference call with analysts to discuss its fourth quarter 2022 results.

MPT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medical Properties Trust, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, May 31, 2023
Medical Properties Trust, MPT, P.C, Telephone, Person, Prospect, District court, MPW, Risk, Defendant, Court, NYSE

Investors have until June 12, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 12, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
  • There is no cost or obligation to you.

ICAHN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Icahn Enterprises L.P. and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, May 31, 2023
P.C, Telephone, Person, Icahn, Icahn Enterprises, District court, Defendant, Court, IEP, Security (finance)

Investors have until July 10, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until July 10, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
  • There is no cost or obligation to you.

Robex Announces Its Results for the First Quarter of Fiscal Year 2023

Retrieved on: 
Tuesday, May 30, 2023
Bridge loan, Business development, TSX Venture Exchange, Senior, Bank statement, Telephone, Business, Disclosure, Ratio, EDT, Sale, Directorate-General for Economic and Financial Affairs, Housekeeping, Growth, Audit, Security (finance), Management, Kiniéro

This line of credit bears interest at an annual rate of 8% and will mature on April 3, 2024.

Key Points: 
  • This line of credit bears interest at an annual rate of 8% and will mature on April 3, 2024.
  • Short-form base shelf prospectus: On May 16, 2023, the Autorité des marchés financiers issued a receipt for the preliminary short-form base shelf prospectus dated May 15, 2023 (the “Preliminary Shelf Prospectus”).
  • Notwithstanding the foregoing, there can be no assurance that the Robex securities will be offered or sold during this 25-month period.
  • Robex will be holding a telephone conference to discuss the results of the first quarter of fiscal year 2023 during a live webcast organized by Renmark Financial on Wednesday, June 7, 2023 at 10:00 a.m., EDT – New York.

Eldorado Gold Announces C$81.5 Million Strategic Investment by the European Bank for Reconstruction and Development (EBRD) and Concurrent C$135 Million Bought Deal Financing

Retrieved on: 
Tuesday, May 30, 2023
International Data Group, New York Stock Exchange, BMO Capital Markets, Indian stock exchange, Private placement, Private, Reconstruction, Placement, Toronto Stock Exchange, Eldorado Gold, Telephone, Enterprise file synchronization and sharing, EDGAR, Sale, EBRD, Suite, National Bank of Canada, Nature, Olympias, Prospectus, EIA, Copper, Offering, ATTN:, Burns, Natural Resources, SEDAR, Form, International Bank for Reconstruction and Development, European Central Bank, Security (finance), Renewable energy

VANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado” or the “Company”) is pleased to announce it has entered into agreements with respect to a C$81.5 million strategic investment in Eldorado by the European Bank for Reconstruction and Development (the "EBRD").

Key Points: 
  • VANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado” or the “Company”) is pleased to announce it has entered into agreements with respect to a C$81.5 million strategic investment in Eldorado by the European Bank for Reconstruction and Development (the "EBRD").
  • In the event that the option is exercised in its entirety, the aggregate gross proceeds of the Offering would be C$155 million.
  • “Proceeds from this financing will strengthen the Company’s balance sheet and is expected to provide additional optionality across our global portfolio.
  • “We are pleased that the EBRD is becoming a shareholder in Eldorado,” said Natalia Lacorzana, Head of Natural Resources at the EBRD.

Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares and Warrants

Retrieved on: 
Tuesday, May 30, 2023
Attention, Therapy, Capital market, Telephone, American depositary receipt, Park Avenue, Enterprise file synchronization and sharing, Research, EDGAR, Sale, Prospectus, State Street, SAN, 4th floor, Form, SVB Securities, Security (finance)

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs, today announced that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one of its ordinary shares, and warrants to purchase ordinary shares represented by ADSs.

Key Points: 
  • SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs, today announced that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one of its ordinary shares, and warrants to purchase ordinary shares represented by ADSs.
  • All of the securities in the offering are to be sold by Belite Bio.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • SVB Securities LLC, Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC are acting as joint book-running managers for the offering.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Telephone and Data Systems, Inc. (TDS)

Retrieved on: 
Tuesday, May 30, 2023
Data, Telephone, TDS, Suite, Investment, Court, Defendant, U.S. Cellular, GPM, NYSE, News, Pharmaceutical industry

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On this news, TDS’s stock price fell $4.29, or 25.9%, to close at $12.28 per share on November 4, 2022, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

DEADLINE ALERT for BYND, DIS, STEM, VTRS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, May 30, 2023
Han Kun Law Offices, Meat, Stem, Partnership, Class, Telephone, Consumer, The Walt Disney Company, AP, Law, Suite, Investment, Growth, Erosion, Beyond Meat, NYSE, Security (finance)

BENSALEM, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

FULC LAWSUIT ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Tuesday, May 30, 2023
Hemoglobinopathy, CASE, LLP, Telephone, COST, Levi, Sickle cell disease, CLASS, NEXT, Court, FDA, Safety, Bone marrow, Cryptocurrency, Fulcrum

NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fulcrum investors who were adversely affected by alleged securities fraud between March 3, 2022 and March 8, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    FULC investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

FHN LAWSUIT ALERT: Levi & Korsinsky Notifies First Horizon Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Tuesday, May 30, 2023
First Horizon Corporation, LLP, FHN, Michael J. Hsu, TD, The Wall Street Journal, Comptroller, First Horizon Bank, Telephone, COST, Toronto-Dominion Bank, Complaint, Levi, Currency, Risk, CLASS, NEXT, Court, NYSE, Cryptocurrency

NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in First Horizon Corporation ("First Horizon" or the "Company") (NYSE: FHN) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in First Horizon Corporation ("First Horizon" or the "Company") (NYSE: FHN) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of First Horizon investors who were adversely affected by alleged securities fraud between February 28, 2022 and May 3, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    FHN investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.